Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
NU E Power Corp. Announces Closing of Non-Brokered Private Placement for $1.7 Million. (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Scancell Holdings PLC (PK)
SCNLF
Healthcare
Biotechnology
Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of small cell lung cancer. It also develops Modi-1, an active peptide immunotherapy that is in phase...
II clinical trials for the treatment of solid tumors, including renal, head and neck, ovarian and triple negative breast cancers; and Modi-2, which targets stress-induced post translational modifications, such as homocittrullination. In addition, the company provides GlyMab platform that generates various affinity tumour specific monoclonal antibodies (mAb) targeting glycans that are over-expressed on cancer cells; and AvidiMab, which romotes receptor clustering thereby improving immune signalling. Scancell Holdings plc was founded in 1996 and is based in Oxford, the United Kingdom.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (PINL:SCNLF)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
MarsBarsAtDawn
X
Post by
MarsBarsAtDawn
on Apr 07, 2014 3:54am
Scancell to give AACR presentation on SCIB1 vaccine
Scancell is to present interim data on their SCIB1 vaccine at this month's Annual Meeting of the American Association for Cancer Research (AACR), held in San Diego. The event kicks off tomorrow
...more
(0)
•••
MarsBarsAtDawn
X
Post by
MarsBarsAtDawn
on Mar 26, 2014 1:59pm
Scancell's remarkable history of success
Scancell, founded in 1997, hit the ground running with an early, protein version, of their ImmunoBody vaccine which successfully treated osteosarcoma. The vaccine was powered by one of Scancell's
...more
(0)
•••
fightfear
X
Comment by
fightfear
on Mar 26, 2014 9:58am
RE:RE:Scancell - breakthrough in cancer treatment
The CEO has said that the first deal he expects to make is for a product from Scancell's Moditope platform. He also said on Investor Day that he doesn't intend to wait for any further
...more
(0)
•••
MarsBarsAtDawn
X
Post by
MarsBarsAtDawn
on Mar 23, 2014 8:55am
New article from Stock Oracle
Scancell Could Explode Any Time! Stock Oracle
(0)
•••
fightfear
X
Comment by
fightfear
on Mar 20, 2014 11:35am
RE:Scancell - breakthrough in cancer treatment
Yervoy $1b revenue in 2 years Bristol Myers has done 18 trials, nearly all of them involve the drug ipilimumab (a bit like Scancell’s immunobody), branded Yervoy, combined with other TKI drugs
...more
(0)
•••
fightfear
X
Post by
fightfear
on Mar 19, 2014 10:55am
Scancell - breakthrough in cancer treatment
I've been long on Scnacell for quite some time, and I've shifted all my funds there, despite promising myself never to be "all in" no mater how good the company looks. It's just
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
A clean tech company on the verge of transformational growth plans to uplist to major US exchange
Vertical integration could reshape this scaling beverage brand’s long-term outlook
Podcasts